Skip to main content

Animations

MJFF Publications

6021 - 6030 of 6295 Results
Title
Year
  • Year
  • 2021
  • 2023
  • 2013
  • 2019
  • 2019
  • 2021
  • 2018
  • 2016
  • 2020
  • 2015
  • Summary Details
    OPEN
    Title: Nurr1 repression mediates cardinal features of Parkinson’s disease in α-synuclein transgenic mice
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/hmg/ddab118
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Population fraction of Parkinson’s disease attributable to preventable risk factors
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00603-z
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Effects of prolonged selective serotonin reuptake inhibition on the development and expression of l-DOPA-induced dyskinesia in hemi-parkinsonian rats
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2013.09.017
    Citation Count: 63
  • Summary Details
    OPEN
    Title: The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron loss
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2019.05.002
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Transcriptome analysis of LRRK2 knock-out microglia cells reveals alterations of inflammatory- and oxidative stress-related pathways upon treatment with α-synuclein fibrils
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2019.05.012
    Citation Count: 63
  • Summary Details
    OPEN
    Title: The East Asian Parkinson Disease Genomics Consortium
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00373-2
    Best OA location URL:
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Inhibition of LRRK2 or Casein Kinase 1 Results in LRRK2 Protein Destabilization
    Journal Name: Molecular Neurobiology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s12035-018-1449-2
    Citation Count: 18
  • Summary Details
    OPEN
    Title: The melanoma‐linked “redhead” MC1R influences dopaminergic neuron survival
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.24852
    Citation Count: 49
  • Summary Details
    OPEN
    Title: Alterations of Brain Signal Oscillations in Older Individuals with HIV Infection and Parkinson’s Disease
    Journal Name: Journal of Neuroimmune Pharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s11481-020-09914-x
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Microglial P2Y12 receptors regulate microglial activation and surveillance during neuropathic pain
    Journal Name: Brain, Behavior, and Immunity
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bbi.2015.11.007
    Citation Count: 122
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.